Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C MacDougall

Showing results (231-240 of 373) with videos related to

Pageof 38
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 30, 2002
Serum erythropoietin levels may be inappropriately low in the acute neuropsychiatric porphyriasAndrea S Winkler, Joanne Marsden, Allan Deacon, et al.
Clinical Nephrology|June 10, 2008
Acute intermittent porphyria and chronic renal failureJ T Marsden, P Chowdhury, J Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1997
Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failureA M Chesser, M C Carroll, C Lightowler, et al.
Pharmacoepidemiology and Drug Safety|February 19, 2015
Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover studyIain A Gillespie, Iain C Macdougall, Sharon Richards, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney diseaseIain C Macdougall, Richard Robson, Sylvie Opatrna, et al.
BMC Nephrology|January 29, 2013
Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial dataOlga Dmitrieva, Simon de Lusignan, Iain C Macdougall, et al.
International Journal of Behavioral Medicine|October 24, 2017
Correction to: Psychosocial and Clinical Correlates of Fatigue in Haemodialysis Patients: the Importance of Patients' Illness Cognitions and BehavioursJoseph Chilcot, Rona Moss-Morris, Micol Artom, et al.
Frontiers in Rehabilitation Sciences|February 23, 2023
Feasibility of randomized controlled trials and long-term implementation of interventions: Insights from a qualitative process evaluation of the PEDAL trialCathy Bulley, Pelagia Koufaki, Jamie Hugo Macdonald, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 2002
Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failureD R Bosman, C A Osborne, J T Marsden, et al.
The American Journal of Cardiology|November 15, 1995
Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies)S Z Goldhaber, D R Hirsch, R C MacDougall, et al.
Pageof 38

Showing results (231-240 of 373) with videos related to

Sort By:
Pageof 38
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 30, 2002
Serum erythropoietin levels may be inappropriately low in the acute neuropsychiatric porphyriasAndrea S Winkler, Joanne Marsden, Allan Deacon, et al.
Clinical Nephrology|June 10, 2008
Acute intermittent porphyria and chronic renal failureJ T Marsden, P Chowdhury, J Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1997
Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failureA M Chesser, M C Carroll, C Lightowler, et al.
Pharmacoepidemiology and Drug Safety|February 19, 2015
Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover studyIain A Gillespie, Iain C Macdougall, Sharon Richards, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney diseaseIain C Macdougall, Richard Robson, Sylvie Opatrna, et al.
BMC Nephrology|January 29, 2013
Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial dataOlga Dmitrieva, Simon de Lusignan, Iain C Macdougall, et al.
International Journal of Behavioral Medicine|October 24, 2017
Correction to: Psychosocial and Clinical Correlates of Fatigue in Haemodialysis Patients: the Importance of Patients' Illness Cognitions and BehavioursJoseph Chilcot, Rona Moss-Morris, Micol Artom, et al.
Frontiers in Rehabilitation Sciences|February 23, 2023
Feasibility of randomized controlled trials and long-term implementation of interventions: Insights from a qualitative process evaluation of the PEDAL trialCathy Bulley, Pelagia Koufaki, Jamie Hugo Macdonald, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 2002
Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failureD R Bosman, C A Osborne, J T Marsden, et al.
The American Journal of Cardiology|November 15, 1995
Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies)S Z Goldhaber, D R Hirsch, R C MacDougall, et al.
Pageof 38